A US Claims-Based Analysis of Real-World Lipid-Lowering Treatment Patterns in Patients with High Cardiovascular Disease Risk or a Previous Coronary Event

American Journal of Cardiology

Volumn 117, Issue 4, 2016, Pages 495-500

  Quek, Ruben G W ^a   Fox, Kathleen M ^b   Wang, Li ^c   Li, Lu ^c   Gandra, Shravanthi R ^a   Wong, Nathan D ^d  

^a AMGEN INC   (United States)

^b Strategic Healthcare Solutions   (United States)

^c STATINMED RESEARCH   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTILIPEMIC AGENT; EZETIMIBE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPID;

ADULT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COHORT ANALYSIS; FEMALE; HEALTH CARE PLANNING; HUMAN; INVESTIGATIVE PROCEDURES; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TIME TO TREATMENT; BLOOD; CARDIOVASCULAR DISEASES; CLINICAL TRIAL; FOLLOW UP; HEALTH INSURANCE; INSURANCE; MIDDLE AGED; MULTICENTER STUDY; RISK FACTOR; TIME FACTOR; UNITED STATES;

CARDIOVASCULAR DISEASES; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPOLIPIDEMIC AGENTS; INSURANCE CLAIM REVIEW; LIPIDS; MALE; MANAGED CARE PROGRAMS; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; UNITED STATES;

EID: 84958852771     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2015.11.035     Document Type: Article

References (26)

1. A.L. Catapano Perspectives on low-density lipoprotein cholesterol goal achievement Curr Med Res Opin 25 2009 431 447
2. Z. Ahmad Statin intolerance Am J Cardiol 113 2014 1765 1771
3. N.J. Stone, J.G. Robinson, A.H. Lichtenstein, C.N. Bairey Merz, C.B. Blum, R.H. Eckel, A.C. Goldberg, D. Gordon, D. Levy, D.M. Lloyd-Jones, P. McBride, J.S. Schwartz, S.T. Shero, S.C. Smith Jr., K. Watson, and P.W. Wilson 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 63 25 Pt B 2014 2889 2934
4. E.S. Stroes, P.D. Thompson, A. Corsini, G.D. Vladutiu, F.J. Raal, K.K. Ray, M. Roden, E. Stein, L. Tokgözoʇlu, B.G. Nordestgaard, E. Bruckert, G. De Backer, R.M. Krauss, U. Laufs, R.D. Santos, R.A. Hegele, G.K. Hovingh, L.A. Leiter, F. Mach, W. März, C.B. Newman, O. Wiklund, T.A. Jacobson, A.L. Catapano, M.J. Chapman, H.N. Ginsberg European Atherosclerosis Society Consensus Panel Statin-associated muscle symptoms: impact on statin therapy - European Atherosclerosis Society Consensus Panel statement on assessment, aetiology and management Eur Heart J 36 2015 1012 1022
5. J.R. Guyton, H.E. Bays, S.M. Grundy, and T.A. Jacobson An assessment by the Statin Intolerance Panel: 2014 update J Clin Lipidol 8 2014 s72 s81
6. G.B. Mancini, S. Baker, J. Bergeron, D. Fitchett, J. Frohlich, J. Genest, M. Gupta, R.A. Hegele, D. Ng, and J. Pope Diagnosis, prevention, and management of statin adverse effects and intolerance: proceedings of a Canadian Working Group Consensus Conference Can J Cardiol 27 2011 635 662
7. A.J. Garver, M.J. Abrahamson, J.I. Barzilay, L. Blonde, Z.T. Bloomgarden, M.A. Bush, S. Dagogo-Jack, M.B. Davidson, D. Einhorn, J.R. Garber, W.T. Garvey, G. Grunberger, Y. Handelsman, I.B. Hirsch, P.S. Jellinger, J.B. McGill, J.I. Mechanick, P.D. Rosenblit, G. Umpierrez, and M.H. Davidson AACE/ACE comprehensive diabetes management algorithm 2015 Endocr Pract 21 2015 438 447
8. IMS Health. Available at: http://www.imshealth.com/deployedfiles/imshealth/Global/Content/Home%20Page%20Content/Real-World%20insights/IMS-Lifelink-pharmetrics-Plus.pdf. Accessed on March 2, 2015.
9. S.M. Grundy, J.I. Cleeman, C.N. Merz, H.B. Brewer Jr., L.T. Clark, D.B. Hunninghake, R.C. Pasternak, S.C. Smith, and N.J. Stone Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines Circulation 110 2004 227 239
10. H. Caspard, A.K. Chan, and A.M. Walker Compliance with a statin treatment in a usual-care setting: retrospective database analysis over 3 years after treatment initiation in health maintenance organization enrollees with dyslipidemia Clin Therapeut 27 2005 1639 1646
11. R.J. Simpson Jr., K. Tunceli, D.R. Ramey, D.R. Neff, D.M. Kern, H.M. Hsieh, D.A. Wertz, J.J. Stephenson, E. Marrett, J.E. Tomassini, and T.A. Jacobson Treatment pattern changes in high-risk patients newly initiated on statin monotherapy in a managed care setting J Clin Lipidol 7 2013 399 407
12. H. Zhang, J. Plutzky, S. Skentzos, F. Morrison, P. Mar, M. Shubina, and A. Turchin Discontinuation of statins in routine care setting Ann Intern Med 158 2013 526 534
13. G. Chodick, V. Shalev, Y. Gerber, A.D. Heymann, H. Silber, V. Simah, and E. Kokia Long-term persistence with statin treatment in a not-for-profit health maintenance organization: a population-based retrospective cohort study in Israel Clin Ther 30 2008 2167 2179
14. L. Degli Esposti, S. Saragoni, P. Batacchi, S. Benemei, P. Geppetti, A. Sturani, S. Buda, and E. Degli Esposti Adherence to statin treatment and health outcomes in an Italian cohort of newly treated patients: results from an administrative database analysis Clin Ther 34 2012 190 199
15. Z. Reiner, A.L. Catapano, G. De Backer, I. Graham, M.R. Taskinen, O. Wiklund, S. Agewall, E. Alegria, M.J. Chapman, P. Durrington, S. Erdine, J. Halcox, R. Hobbs, J. Kjekshus, P.P. Filardi, G. Riccardi, R.F. Storey, D. Wood ESC Committee for Practice Guidelines (CPG) 2008-2010 and 2010-2012 Committees ESC/EAS guidelines for the management of dyslipidaemias: the Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS) Eur Heart J 32 2011 1769 1818
16. M.A. Silva, A.C. Swanson, P.J. Gandhi, and G.R. Tataronis Statin-related adverse events: a meta-analysis Clin Ther 28 2006 26 35
17. E. Bruckert, G. Hayem, S. Dejager, C. Yau, and B. Begaud Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients - the PRIMO study Cardiovasc Drugs Ther 19 2005 403 414
18. J.D. Cohen, E.A. Brinton, M.K. Ito, and T.A. Jacobson Understanding Statin Use in America and Gaps in Patient Education (USAGE): an internet-based survey of 10,138 current and former statin users J Clin Lipidol 6 2012 208 215
19. B.A. Parker, J.A. Capizzi, A.S. Grimaldi, P.M. Clarkson, S.M. Cole, J. Keadle, S. Chipkin, L.S. Pescatello, K. Simpson, C.M. White, and P.D. Thompson Effect of statins on skeletal muscle function Circulation 127 2013 96 103
20. C. Buettner, M.J. Rippberger, J.K. Smith, S.G. Leveille, R.B. Davis, and M.A. Mittleman Statin use and musculoskeletal pain among adults with and without arthritis Am J Med 125 2012 176 182
21. D.M. Kern, S. Balu, O. Tuncelli, and D. Anzalone Statin treatment patterns and clinical profile of patients with risk factors for coronary heart disease defined by National Cholesterol Education Program Adult Treatment Panel III Curr Med Res Opin 30 2014 2443 2451
22. R.H. Chapman, J.S. Benner, P. Girase, M. Benigno, K. Axelsen, L.Z. Liu, and M.B. Nichol Generic and therapeutic statin switches and disruptions in therapy Curr Med Res Opin 25 2009 1247 1260
23. C.R. Harley, S.K. Gandhi, N. Anoka, M.F. Bullano, and J.M. McKenney Understanding practice patterns and low-density lipoprotein cholesterol goal attainment implications of switching patients from simvastatin in a health plan setting Am J Manag Care 13 2007 S276 S281
24. H.E. Bays, P.H. Jones, W.V. Brown, and T. Jacobson National Lipid Association Annual Summary of Clinical Lipidology 2015 J Clin Lipidol 8 2014 S1 S36
25. Centers for Disease Control and Prevention (CDC) National Health Report: leading causes of morbidity and mortality and associated behavioral risk and protective factors - United states, 2005-2013 MMWR Surveill Summ 63 2014 3 27
26. C.R. Harley, S. Gandhi, J. Blassetto, H. Heien, R. Sasane, and S.P. Nelson Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice Am J Geriatr Pharmacother 5 2007 185 194